June 2010

ACRP 2010 Global Conference & Exhibition Wrap Up

May 27, 2010

The Association of Clinical Research Professionals (ACRP) remains steadfast in its mission to provide value and excellence to conference participants against a backdrop of continued economic and regulatory challenges to individuals and businesses. This year’s conference featured 55 sessions and 226 speakers.

Adaptive by Design

May 25, 2010

Adaptive trial designs have the potential to speed development and reduce overall costs — that is, if sponsors invest in up-front planning and can implement these designs correctly. Interest in adaptive designs has risen in recent years. These types of studies involve a broad class of methods and can have a positive impact on any […]

2010 DIA Preview

May 24, 2010

PharmaVOICE is pleased to once again publish this Special Feature showcasing the new products, services, tools, and executive appointments and promotions at clinical-services ­companies that will be exhibiting at the DIA 46th Annual Meeting, June 13-17, 2010, in Washington, D.C. For your convenience, we’ve divided the briefs into sections, including E-Solutions, What’s New, and People. […]

View on Diversity in Clinical Trials

May 24, 2010

Rapidly changing demographics are shifting the texture and fabric of American society. So-called niche markets have become “minority-majority” markets. Current healthcare reform that is focusing on better outcomes will only place more pressure on study sponsors to demonstrate to regulators that their clinical trials include all of the populations that will actually use the prescription […]

Dr. Nancy Simonian: One for All

May 24, 2010

There’s no place for the arch ego in today’s most progressive biotechnology companies or for that matter, at pharmaceutical companies. Rather, scientific leaders such as Nancy Simonian, M.D., are leading the charge toward collaborative ingenuity. Teamwork is very much Dr. Simonian’s mantra. Indeed, it is the collaborative spirit of biotechnology that spurred Dr. Simonian to […]

The Power of the Cloud

May 24, 2010

When Dave Powers, senior systems engineer, research and development IT at Eli Lilly and Company, talks about the advantages of cloud computing in the life-sciences industry, he gets pretty excited — as do others who have experienced first hand the benefits of the cloud. According to our thought leaders, cloud computing is game changing in […]

Mixed Media: The Best Ways to Reach Physicians in 2010

May 24, 2010

When considering how to successfully communicate with each physician, it is vital to consider individual physicians, their specialty, their current use of technology, their comfort level for learning new technologies, and their personal preferences for receiving information, says Cherie Hicks, president of CMR Institute. “Ultimately, successful communication is dependent on the message, regardless of the […]

Last Word

May 24, 2010

GLOBAL NEEDS What do you think is the biggest global health need? Joseph. As citizens of the developed world, we don’t often think about infectious and tropical diseases but malaria and tuberculosis, along with HIV, are alarmingly prevalent among the poorest people in the world. Every year, these and other infectious diseases kill millions of […]

Talent Pool

May 24, 2010

Pharmaceutical POOL Dr. Roger POMERANTZ Merck Appoints Head of Infectious Diseases Merck has named Roger Pomerantz, M.D., senior VP of Merck Research Laboratories (MRL) and infectious diseases franchise head. Dr. Pomerantz spent the last five years at Johnson & Johnson, where he most recently served as global head of infectious diseases and president of Peninsula […]


May 24, 2010

New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: AAPS Relaunches Online Career Center QuestaWeb Adds to Global Trade ­Management Suite SAS Releases Social Media Enterprise Solution Web Site Provides PwC Health Reform Insights Sidebar: E-upgrades and enhancements Follow up THE AMERICAN ASSOCIATION OF PHARMACEUTICAL SCIENTISTS provides a dynamic international forum for the exchange […]

What’s New

May 24, 2010

SciQuest has launched the Procurement Business Assessment, a service that enables life-sciences companies to uncover cost-saving opportunities in their procurement operations. Procurement professionals often lack the resources and time to conduct the deep analysis of purchasing processes, systems, and protocols needed to optimize their operations. “Merger and acquisition activity, growth into emerging markets, and increased […]


May 24, 2010

n The value of the global market for therapeutic vaccines is estimated at $137 million in 2010, but the market entry of new vaccines to treat cancer and nicotine addiction is expected to propel the category to almost $3.1 billion in 2014, for a four-year compound annual growth rate (CAGR) of 117.7%. Source: BCC Research, […]


May 24, 2010

Reputation malaise has made the U.S.-based pharmaceutical industry vulnerable to “Beltway advocacy.” Science has lost its life-enhancing societal mystique and at risk is its intellectual property. Drug-discovery successes and the stellar reputation of the 1980s and 1990s — driving breakthrough treatments for AIDS, cancers, heart disease, and even once-considered deadly rare disorders — occur in […]


May 24, 2010

Awards CURE Awards ­Bioscience Achievements Pfizer was awarded the CURE (Connecticut United for Research Excellence) Award for Excellence for its investment in multiple approaches to treating Alzheimer’s disease. Pfizer has seven Alzheimer’s ­clinical projects ongoing and ­several more programs in earlier stages of ­development at its Groton research site. The CURE New ­Operations Award was […]

Raise Your Voice

May 24, 2010

A personal journey Many of you are no doubt in the midst of data locks, publication deadlines, protocol designs, audits, IRB meetings, accreditation, investigator meetings, or the myriad of events that make up each of our days. If you are reading this letter, we likely met as clinical research colleagues, and if we haven’t met […]

Letter from the Editor

May 24, 2010

Generics coming home to roost… By now, everyone in the pharmaceutical industry realizes that billions and billions of sales of branded products are going away, and the impact of this is going to be huge. According to IMS Health, the 5% to 8% compound annual growth rate during the next five years is going to […]